These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20561311)

  • 21. Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
    Sendi P; Günthard HF; Simcock M; Ledergerber B; Schüpbach J; Battegay M;
    PLoS One; 2007 Jan; 2(1):e173. PubMed ID: 17245449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials.
    Benjamin DK; Hirschfeld S; Cunningham CK; McKinney RE
    J Antimicrob Chemother; 2004 Oct; 54(4):701-3. PubMed ID: 15355940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.
    Ivers LC; Kendrick D; Doucette K
    Clin Infect Dis; 2005 Jul; 41(2):217-24. PubMed ID: 15983918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa.
    Giaquinto C
    Scand J Infect Dis Suppl; 2003; 106():88-90. PubMed ID: 15000594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term therapeutic strategies in HIV.
    Miles SA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S36-41. PubMed ID: 9389314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early treatment makes it possible: an almost normal life with HIV].
    Bogner J
    MMW Fortschr Med; 2011 May; 153(18):22. PubMed ID: 21604587
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment. Supplements improve ART success in Africa.
    AIDS Policy Law; 2014 Jul; 29(8):1. PubMed ID: 25151678
    [No Abstract]   [Full Text] [Related]  

  • 30. Simply Rob: advocate and artist, a man of words uses them to spread truth.
    Nass HM
    Posit Aware; 2012; 24(4):18-21. PubMed ID: 23094304
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of neuropsychology in UK pediatric HIV care: Relevance to clinical practice and research.
    Freeman A
    Child Neuropsychol; 2017 Nov; 23(8):1003-1012. PubMed ID: 27424679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reflections: A Case for Intersectional Approaches in HIV Research.
    Caiola C; McGee K; Harmon JL
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):669-70. PubMed ID: 26061807
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of quality of life of HIV individuals: Perspectives & future directions.
    Casado A
    Indian J Med Res; 2005 Oct; 122(4):282-4. PubMed ID: 16394316
    [No Abstract]   [Full Text] [Related]  

  • 34. Author response.
    Parrott JS; Kietrys DM; Galantino ML
    Phys Ther; 2014 Sep; 94(9):1356-8. PubMed ID: 25320740
    [No Abstract]   [Full Text] [Related]  

  • 35. Buying time.
    Carr P
    Home Healthc Nurse; 1992; 10(3):63. PubMed ID: 1607291
    [No Abstract]   [Full Text] [Related]  

  • 36. [HIV drug tenders are not in the patient’s best interest].
    Hansen LO
    Tidsskr Nor Laegeforen; 2019 Jan; 139(2):. PubMed ID: 30698396
    [No Abstract]   [Full Text] [Related]  

  • 37. Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal.
    Mbengue MAS; Sarr M; Diaw PA; Diall PAN; Toure MD; Faye NFFN; Gueye B; Kane NCT; Mboup S
    Afr J Lab Med; 2016; 5(2):440. PubMed ID: 28879122
    [No Abstract]   [Full Text] [Related]  

  • 38. Roadmap for clinical research in resource-constrained settings.
    Sharma D; Agrawal V; Agarwal P
    Trop Doct; 2021 Jan; 51(1):4-5. PubMed ID: 34320874
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality of life assessment in HIV clinical research in resource-limited settings: better late than never.
    Becquet R; Burgos-Soto J; Carrieri MP; Spire B
    Trop Med Int Health; 2010 Sep; 15(9):1008-10. PubMed ID: 20561311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.